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Problem Definition
The assessment of suspected adrenal 
insufficiency (AI) in the hospitalized patient can 
be diagnostically challenging given the complexities 
of concurrent critical illness, lack of standardization 
of AI testing and poor reliability of results in such 
patients. For hospitalized patients without septic 
shock or an established diagnosis of AI, the role of 
glucocorticoid therapy must be determined on a 
case-by-case basis depending on clinical suspicion 
for AI and level of acuity.
It should be noted that overuse of adrenal function 
testing in the general hospitalized patient 
population can lead to misdiagnosis of AI in many 
cases due the inherent frequency of false positive 
results, particularly in patients with low protein 
states. Such adverse events are largely resultant 
from the complex nature of testing for AI and lack of 
standardization. Unfortunately, this may result in 
cost ineffectiveness, inappropriate treatment, 
patient duress and prolonged length-of-stay (LOS).
Aims For Improvement
It is the purpose of our quality improvement project 
to assist in identification of patients in whom testing 
for AI may be most appropriate and to address 
barriers to performing testing correctly via an 
inpatient ACTH-stimulation order set.
Intervention
We reviewed available data from adrenal function 
testing and ACTH-stimulation testing performed 
within our institution and attempted to analyze 
the identifiable barriers to appropriate and correct 
testing. In doing so, we have designed a provider-
driven order set to improve ease and accuracy of 
adrenal function testing.
Measurement and Results
In reviewing data from the chart of 34 patients hospitalized at 
Thomas Jefferson University Hospital (TJUH) in whom adrenal 
function and ACTH-stimulation testing were performed, we learned 
that testing is often incomplete or yields uninterpretable results
• Timing: Many random ACTH and random cortisol levels are 
obtained outside of the ‘7-10 AM’ window in which these tests 
should be obtained to optimize diagnostic accuracy.
• Clinical Yield: 26% (9/34) had a ‘failed’ test result diagnostic 
of AI; 74% had an inconclusive or normal test (Figure 1.)
• Frequent Reasons for Testing: Frequency 
of nondiagnostic testing highlights the need to better 
identify those patients for which alternative diagnoses may be 
more highly considered and unnecessary testing can be avoided
• Hypotension was the most common indication 
(28%, 10/34) for testing. In this group, only one (10%) had 
a clinically significant or 'failed' ACTH-stim test; 
the majority were diagnosed with sepsis. (Figure 2.)
• PPV of Baseline Cortisol: Baseline cortisol levels were 
analyzed with aim of identifying levels predictive of AI 
as confirmed by subsequent ACTH-stimulation testing (Figure 3).
• 100% of patients with baseline AM cortisol >10 later 
had a normal or ‘passing’ ACTH-stimulation
• >90% of patients with baseline cortisol levels <5 
had a significant or ‘failing’ test
• PPV were less consistent those with baseline cortisol levels 
in the 5-10 range therefore suggesting a higher 
utility and potential value of confirmatory testing in 
this subset.
Next Steps and Lessons Learned
While this data is limited and represents a small subset of 
patients, it is supportive of the need for a standardized 
institutional protocol for adrenal function. It is the aim of 
our project to streamline the intricate process of adrenal 
function testing in the hospital setting while minimizing 
costs of testing, reducing LOS, enhancing patient safety 
and improving clinical outcomes.
We have devised a provider-driven ACTH-
stimulation order set that is educational, user-friendly and 
aimed at standardizing adrenal function testing. Within 
the body of this order set will be succinct and relevant 
information regarding indications for testing, variables 
that can confound results and cost of each component of 
testing requested (cortisol, ACTH, ACTH-stimulation). The 
order set (summary below) will include procedural 
instructions regarding optimal timing/sample processing 
and information regarding result interpretation.
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Pretesting Considerations: Identify alternative diagnoses that may 
confound results and consider degree of suspicion for AI
Procedure
1. Baseline serum cortisol and ACTH levels (7-10A)
2. Inject 250 mcg cosyntropin (ACTH) intravenously (or IM if unable to 
obtain IV access) immediately after baseline labs
3. Obtain 60-minute cortisol level (time-marked)
Interpretation of results:
A rise in cortisol level to greater than 18 ug/dl within 60 minutes 
demonstrates a normal result.
A rise in cortisol to less than 18 ug/dl demonstrates an abnormal 
response(. If insufficient response to cosyntropin (syntethetic ACTH), the 
patient may have suppressed adrenal gland function and may benefit 
from glucocorticoid replacement.)
An elevated baseline ACTH level with low cortisol is suggestive 
of primary adrenal failure.
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